Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT)
Rong He, Wei Ding, David S. Viswanatha, et al.
The American Journal of Surgical Pathology (2018) Vol. 42, Iss. 7, pp. 843-854
Closed Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
Yilun Wu, Weiyu Chen, Zhi Ping Xu, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 354
Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
Othman Al‐Sawaf, Sandra Robrecht, Jasmin Bahlo, et al.
Leukemia (2020) Vol. 35, Iss. 1, pp. 169-176
Closed Access | Times Cited: 85
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
Nitin Jain, Jayastu Senapati, Beenu Thakral, et al.
Blood Advances (2022) Vol. 7, Iss. 10, pp. 1958-1966
Open Access | Times Cited: 53
Biology and Treatment of Richter Transformation
Adalgisa Condoluci, Davide Rossi
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 42
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Rory Bennett, John F. Seymour
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Targeting natural killer cells: from basic biology to clinical application in hematologic malignancies
Juanjuan Shang, Shunfeng Hu, Xin Wang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
Alessandra Tedeschi, Anna Maria Frustaci, Adalgisa Condoluci, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 10, pp. 1298-1309
Closed Access | Times Cited: 8
Richter syndrome: Novel insights into the biology of transformation
Erin M. Parry, Elisa ten Hacken, Catherine J. Wu
Blood (2023)
Open Access | Times Cited: 21
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
Othman Al‐Sawaf, Rudy Ligtvoet, Sandra Robrecht, et al.
Nature Medicine (2023) Vol. 30, Iss. 1, pp. 240-248
Open Access | Times Cited: 18
Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era
Robert Briski, Justin Taylor
Cancers (2023) Vol. 15, Iss. 6, pp. 1857-1857
Open Access | Times Cited: 13
Current Trends in the Management of Richter’s Syndrome
John N. Allan, Richard R. Furman
International Journal of Hematologic Oncology (2018) Vol. 7, Iss. 4
Open Access | Times Cited: 45
Richter transformation in the era of novel agents
Wei Ding
Hematology (2018) Vol. 2018, Iss. 1, pp. 256-263
Open Access | Times Cited: 43
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Bei Hu, Ryan Jacobs, Nilanjan Ghosh
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 6, pp. 543-554
Closed Access | Times Cited: 40
Revisiting Richter transformation in the era of novel CLL agents
Anna Petráčková, Peter Turcsányi, Tomáš Papajík, et al.
Blood Reviews (2021) Vol. 49, pp. 100824-100824
Open Access | Times Cited: 29
Treatment of Richter's syndrome
Philip A. Thompson, Tanya Siddiqi
Hematology (2022) Vol. 2022, Iss. 1, pp. 329-336
Open Access | Times Cited: 20
Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells
Aishwarya Ravindran, Surendra Dasari, Gordon Ruan, et al.
Modern Pathology (2023) Vol. 36, Iss. 10, pp. 100268-100268
Open Access | Times Cited: 12
Clinicopathological evaluation of the programmed cell death 1 (PD1)/programmed cell death‐ligand 1 (PD‐L1) axis in post‐transplant lymphoproliferative disorders: association with Epstein–Barr virus, PD‐L1 copy number alterations, and outcome
Luis Veloza, Cristina Teixidó, Natalia Castrejón de Anta, et al.
Histopathology (2019) Vol. 75, Iss. 6, pp. 799-812
Closed Access | Times Cited: 29
Emerging Therapies for the Management of Richter Transformation
Elizabeth Smyth, Toby A. Eyre, Chan Y. Cheah
Journal of Clinical Oncology (2022) Vol. 41, Iss. 2, pp. 395-409
Closed Access | Times Cited: 15
Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma
Siba El Hussein, L. Jeffrey Medeiros, Kirill A. Lyapichev, et al.
Pathology (2023) Vol. 55, Iss. 4, pp. 514-524
Open Access | Times Cited: 8
Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
Yucai Wang, Sutapa Sinha, Linda Wellik, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
Paul J. Hampel, Hua‐Jay J. Cherng, Timothy G. Call, et al.
Blood Advances (2020) Vol. 4, Iss. 18, pp. 4508-4511
Open Access | Times Cited: 19
The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas
Marcos Garcia-Lacarte, Sara C. Grijalba, Javier Melchor, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4683-4683
Open Access | Times Cited: 17
Richter’s Transformation
Audrey M. Sigmund, Adam S. Kittai
Current Oncology Reports (2022) Vol. 24, Iss. 8, pp. 1081-1090
Closed Access | Times Cited: 11
Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome
Hélène Augé, Anne-Béatrice Notarantonio, Romain Morizot, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
Activating the Antitumor Immune Response in Non-Hodgkin Lymphoma Using Immune Checkpoint Inhibitors
Maansi Joshi, Stephen M. Ansell
Journal of Immunology Research (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top